Insys Therapeutics, Inc. 4
4 · Insys Therapeutics, Inc. · Filed Jan 17, 2017
Insider Transaction Report
Form 4
Vetticaden Santosh
Interim CEO and CMO
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-12+30,000→ 30,000 totalExercise: $10.39Exp: 2027-01-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 12, 2021.